ArticleRegenerative therapy2026
Therapeutic effects of Tetramethylpyrazine on Cartilage in Rat Model of Post-traumatic Osteoarthritis.
Article in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-traumatic Osteoarthritis (PTOA) is a common secondary joint disease characterized by cartilage degradation, subchondral bone remodeling, and synovial inflammation following joint trauma. Current therapeutic options are limited in reversing pathological progression. Tetramethylpyrazine (TMP), an active alkaloid extracted from traditional Chinese medicine Ligusticum chuanxiong, exhibits anti-inflammatory, antioxidant, and cartilage protective properties. This study aimed to investigate the therapeutic effects of TMP in a rat model of PTOA. Methods: Sixty-three male Sprague-Dawley rats were randomly divided into sham and model groups. PTOA was induced using a modified Hulth method (anterior cruciate ligament and medial collateral ligament transection plus medial meniscectomy). Four weeks post-surgery, rats were intra-articularly administered TMP (2, 4, or 8 mg/kg) or hyaluronic acid sodium (HA, positive control) for 5 weeks. Functional recovery was assessed using grip strength and gait analysis. Cartilage and subchondral bone changes were evaluated by Micro-CT and histopathological staining (HE and safranin O-fast green). Immunohistochemistry was used to detect cartilage matrix components (COL II, MMP13 and ADAMTS5) at the protein level, while qRT-PCR was performed to validate the gene level of Results: TMP significantly improved grip strength and normalized gait parameters in PTOA model rats. Micro-CT revealed that TMP attenuated subchondral bone loss and improved trabecular microarchitecture. Histological analysis showed that TMP restored cartilage surface integrity, increased chondrocyte density, and enhanced matrix staining. TMP significantly downregulated MMP13 and ADAMTS5 protein expression while upregulating COL II protein. Similarly, TMP restored Conclusion: Intra-articular administration of TMP effectively restored joint function and ameliorated PTOA progression in model rats by promoting cartilage matrix repair, inhibiting inflammatory responses, and improving subchondral bone microstructure. These findings suggest TMP as a potential therapeutic agent for PTOA treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.